Nalmefene hydrochloride dihydrate

Details for Australian Patent Application No. 2009321898 (hide)

Owner Biotie Therapies Corp. H. Lundbeck A/ S

Inventors Lopez De Diego, Heidi; De Faveri, Carla; Huber, Florian Anton Martin

Agent Spruson & Ferguson

Pub. Number AU-A-2009321898

PCT Pub. Number WO2010/063292

Priority PA200801729 05.12.08 DK

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

C07D 489/08 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 July 2011 Amendment Made

  The nature of the amendment is: Amend the priority details to read PA200801729 05 Dec 2008 DK 2009322055 Medela Holding AG The nature of the amendment is as shown in the statement(s) filed 01 Jun 2011

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/063292 Priority application(s): WO2010/063292

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009321899-Optical sectioning of a sample and detection of particles in a sample

2009321894-Barley and malt-derived beverages with low dimethyl sulfide level